Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation, Restricted Stock and Stock Options (Details)

v3.20.4
Stock-Based Compensation, Restricted Stock and Stock Options (Details) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Total stock-based compensation $ 1,633,338 $ 1,352,111 $ 10,965,103 $ 4,218,476
Research and development expenses [Member]        
Total stock-based compensation 661,054 455,820 1,954,426 1,437,334
Selling, general and administrative expenses [Member]        
Total stock-based compensation $ 972,284 $ 896,291 $ 9,010,677 $ 2,781,142